A leptin dose-response study in obese (ob/ob) and lean (+/?) mice

Area of Science:

• Metabolic research
• Endocrinology
• Obesity research

Background:

• Leptin is a crucial hormone regulating energy balance and metabolism.
• Leptin deficiency in ob/ob mice leads to severe obesity and metabolic abnormalities.
• Understanding leptin's dose-dependent effects is vital for therapeutic strategies.

Purpose of the Study:

• To determine the precise dosage of leptin needed to ameliorate specific abnormalities in leptin-deficient mice.
• To investigate the dose-response relationship of leptin administration on food intake, body weight, and metabolic markers.
• To explore the impact of leptin on thermoregulation and sympathetic nervous system activity.

Main Methods:

• Obese (ob/ob) and lean (+/?) C57BL/6J mice were used.
• Human leptin was administered via osmotic pumps at doses ranging from 0 to 42 microg/day for 7 days.
• Body weight, food intake, serum glucose and insulin, hypothalamic serotonin, fat pad weights, liver composition, rectal temperature, and brown adipose tissue uncoupling protein expression were measured.

Main Results:

• Leptin doses as low as 2 microg/day reduced food intake and body weight in ob/ob mice.
• 10 microg/day of leptin normalized serum insulin and glucose levels and reduced fat pads and liver parameters.
• Higher leptin doses (10 and 42 microg/day) corrected low body temperature and increased brown adipose tissue activity.
• Lean mice showed only transient food intake reduction and weight loss at the highest leptin doses.

Conclusions:

• Ob/ob mice exhibit enhanced sensitivity to leptin replacement therapy.
• Leptin effectively reverses obesity and associated metabolic dysfunctions in a dose-dependent manner.
• Increased body temperature and sympathetic activity appear to be indirect consequences of high-dose leptin administration.